Drug intelligence / Profile preview

inactivated split-virion 2009 pandemic influenza a h1n1 vaccine

Development stage: Phase 2
Lead developer: Shanghai Institute of Biological Products
Modality: Vaccines & Immunotherapeutics
Administration: Intramuscular, Subcutaneous, Transdermal, Intraperitoneal

Overview

The inactivated split-virion 2009 pandemic influenza A H1N1 vaccine is a biological product designed to provide immunity against the 2009 pandemic influenza A H1N1 virus. It is an inactivated vaccine, meaning it contains killed virus particles, and is a split-virion type, indicating that the virus has been chemically disrupted to present only key antigens. The vaccine is being investigated for its immunogenicity and safety, particularly in infants.

Other names: H1N1 influenza A vaccine (split virion), inactivatedmonovalent H1N1 vaccinesplit-virion H1N1 vaccineinactivated H1N1 vaccine

Targets

HA (Hemagglutinin of 2009 H1N1 influenza A virus)

Beyond the preview

Go deeper on inactivated split-virion 2009 pandemic influenza a h1n1 vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on inactivated split-virion 2009 pandemic influenza a h1n1 vaccine.

Explore the full profile